Verdot IPS² is based in Riom, in France's Puy-de-Dôme region. It designs and produces a complete range of purification equipment for the biopharmaceutical, pharmaceutical, cosmetology, and food processing industries (primarily chromatography columns and skids). This technology is critical for the development and production of active ingredients for drugs, vaccines, and biotechnological products. Its clients are primarily major players in the pharmaceutical industry (Top 10 Big Pharma companies & subcontractors) and French and international biotech firms.
Very few companies worldwide master this cutting-edge technology and meet the stringent regulatory requirements for pharmaceutical product certification. Verdot IPS² has developed unique expertise, know-how, and agility in responding to complex tenders (customized equipment) and managing production lead times, a key asset in the current high-demand environment.
With an average annual growth rate of 15% since 2015, Verdot IPS² will achieve approximately €13.5 million in revenue in 2020, nearly 90% of which will be generated internationally. It has 40 employees, including 20 or so engineers. With Capital Export's support, Verdot IPS² will keep expanding its product range and accelerate its international deployment, particularly in China and North America, while continuing its sectoral diversification.
Capital Export will also help Verdot IPS² deepen its ESG policy, a key part of the company’s strategy. Progress has already been made in establishing and monitoring non-financial indicators (training, quality, employee safety, resource use, and environmental impact).
.png)
